Today: 11 februari 2026
Subscribe
Search result

Phantom 4 RTK/feed/category/dji-mavic-3t-pl- Page 273

Palantir’s Shocking Reinvention: From Secretive Spy Tech to $400B Cult Lifestyle Brand

Palantir’s ‘Otherworldly’ Earnings & Wegovy Deal Buzz Spark After-Hours Stock Fireworks

Palantir shares rose after Q3 results beat estimates and the company raised its outlook for a third straight quarter, citing surging AI platform demand. Hims & Hers stock jumped 7% post-market as it entered talks to offer Novo Nordisk’s Wegovy, despite mixed earnings. Sarepta plunged over 20% after a key Duchenne drug trial failed its main goal. Sanmina soared 18% on a strong earnings beat and guidance far above Wall Street forecasts.
4 november 2025
·
Palantir’s $500 Billion AI Surge: Record Earnings, Stock Whiplash & What’s Next for PLTR

Palantir’s $500 Billion AI Surge: Record Earnings, Stock Whiplash & What’s Next for PLTR

Palantir’s Q3 2025 revenue surged 63% year-over-year to $1.18 billion, with adjusted EPS of $0.21, beating estimates and raising full-year guidance to $4.4 billion. Shares hit a record near $220 before dropping 4% as investors took profits. U.S. commercial revenue more than doubled, now surpassing government sales. The stock remains volatile, with analysts split over its high valuation.
4 november 2025
··
Lenskart IPO Frenzy: Sky-High Valuation Meets Surging Demand – Will Investors See Big Gains?

Lenskart IPO Frenzy: 7x Oversubscribed Amid Grey Market Jitters – Is Groww’s IPO the Safer Bet?

Lenskart’s ₹7,278 crore IPO was subscribed about 7 times, led by non-institutional bids at 10.2×. Shares list November 10, with grey market premiums cooling to ~14% above the ₹402 issue price. The IPO values Lenskart near ₹70,000 crore, or ~235× FY25 earnings, sparking debate over rich pricing. Brokerages mostly recommend subscribing, but some experts warn of stretched valuations and possible correction.
4 november 2025
Bitcoin Miner to AI Cloud Sensation: Why Iris Energy (IREN) Stock Is Soaring in 2025

From Bitcoin Miner to AI Cloud Powerhouse: Iris Energy’s Meteoric Rise (IREN Stock Soars on $9.7B Microsoft Deal)

Iris Energy (IREN) closed at $67.75 on Nov. 3, 2025, after announcing a $9.7 billion, five-year AI cloud contract with Microsoft, sending shares up 11.5%. The company’s market cap now tops $16.5 billion, up from $1 billion at the start of 2025. IREN posted FY2025 revenue of $501 million and net income of $86.9 million, driven by its pivot to AI cloud services and continued Bitcoin mining.
4 november 2025
···
Kimberly-Clark’s $40 Billion Gamble Sends KMB Stock Plunging – What’s Next for This Dividend King?

Kimberly-Clark’s $40 Billion Gamble Sends KMB Stock Plunging – What’s Next for This Dividend King?

Kimberly-Clark shares plunged 14.6% on Nov. 3 to a 52-week low near $102 after announcing a $40 billion cash-and-stock deal to acquire Kenvue at a 46% premium. The drop erased about 15% of KMB’s market value, with the stock now down 21% year-over-year. Investors cited concerns over Kenvue’s litigation risks and debt load. KMB trades at 17.3× earnings, with a 4.9% dividend yield.
4 november 2025
··
Scienture Holdings (SCNX) Surges on Coverage Breakthrough – Can This Pharma Underdog Deliver?

Scienture Holdings (SCNX) Surges on Coverage Breakthrough – Can This Pharma Underdog Deliver?

Scienture (SCNX) shares surged 40% to $0.99 pre-market Nov. 4 after its hypertension drug Arbli™ was added to major insurance formularies, expanding coverage to over 100 million people. The company reported just $0.13 million in revenue and a $20 million net loss over the past year. SCNX trades near $0.71, down from a 52-week high of $8.81. Analysts remain cautious, citing high cash burn and uncertain Arbli sales.
4 november 2025
·
Stanley Black & Decker (SWK) Stock: Big Earnings Beat, 5% Dividend – Rebound Ahead in 2025?

Stanley Black & Decker (SWK) Stock: Big Earnings Beat, 5% Dividend – Rebound Ahead in 2025?

Stanley Black & Decker shares closed at $66.36 on Nov. 3, 2025, down 2% and roughly 32% below their 52-week high. Q3 adjusted EPS beat estimates at $1.43, but revenue was flat at $3.75–3.76 billion and GAAP EPS fell to $0.34 due to a $169 million impairment charge. Management cut full-year profit guidance, citing higher costs. The dividend yield stands near 5%.
4 november 2025
··
Upwork Stock Soars on AI-Fueled Earnings Beat – Key Facts & Expert Outlook

Upwork Stock Soars on AI-Fueled Earnings Beat – Key Facts & Expert Outlook

Upwork reported Q3 2025 revenue of $201.7 million, beating estimates, and raised its full-year outlook above consensus. Shares surged nearly 20% to around $17 after the results. Wall Street analysts boosted price targets, with Goldman Sachs setting a $25 target citing AI-driven growth. AI-related freelance work on the platform jumped 53% year-over-year.
4 november 2025
···
Apple Stock Could Explode After New AI Chip Launch and iPhone 17 “Supercycle,” Analysts Say

Apple Stock Soars to Record High After Huge Q4 Earnings Beat – What’s Next for AAPL in 2025?

Apple traded near $269 on Nov. 4, 2025, close to its 52-week high of $277.32, with shares up 26% since August and market cap at $3.95 trillion. The company reported record Q4 revenue of $102.5 billion, up 8% year-over-year, and forecast double-digit iPhone sales growth for the holiday quarter. Analyst targets are split, with consensus near $285. Technical resistance is seen at $275–$280.
4 november 2025
···
Oriental Rise’s Wild Tea Ride: From $56 High to Penny Stock – 2025’s Shocking Ups and Downs Revealed

Oriental Rise’s Wild Tea Ride: From $56 High to Penny Stock – 2025’s Shocking Ups and Downs Revealed

Oriental Rise Holdings (NASDAQ: ORIS) closed at $0.19 on Nov 4, 2025, down 95% from its IPO, after a year of extreme volatility and a July share offering that triggered a 66% one-day crash. The China-based tea company reported 2024 revenue of $15 million (–38% YoY) and net income of $2.09 million (–82%), despite holding $43 million in cash and no debt. ORIS risks Nasdaq delisting unless it regains compliance by Dec 29.
4 november 2025
·
Pixel 10 vs. iPhone 17 – 2025 Flagship Showdown Leaks Reveal Shocking Upgrades

Pixel 10 Price Earthquake: Google’s Entire Lineup Just Dropped—Here’s What’s Real, What’s Hype, and What It Means for Your Wallet (and Alphabet’s Stock)

Google’s Pixel 10 lineup is discounted through Nov 9, with the Pixel 10 Pro Fold at $1,499—its first major price cut since launch. Deals are live at Amazon, Best Buy, and Google Store. The Pixel 10 series adds Qi2 magnetic charging; the Fold is the first IP68-rated foldable. Alphabet’s Q3 2025 revenue reached $102.3 billion, up 16% year-over-year.
5 november 2025
·
Arista Networks Stock Skyrockets 40% YTD on AI Boom – But Q3 Guidance Triggers Pullback

Arista Networks Stock Skyrockets 40% YTD on AI Boom – But Q3 Guidance Triggers Pullback

Arista Networks shares surged nearly 40% year-to-date in 2025, far outpacing the S&P 500. The stock hit a record high in late October before dropping about 12% after Q3 earnings, as guidance signaled flat Q4 revenue and lower margins. Q3 revenue rose 27.5% to $2.31 billion, beating estimates. Most analysts remain positive, but some cite high valuation and slowing growth.
5 november 2025
·
Roche’s $3.5B Bet on 89bio (ETNB) – Stock Soars to New Highs as NASH Breakthrough Looms

Roche’s $3.5B Bet on 89bio (ETNB) – Stock Soars to New Highs as NASH Breakthrough Looms

Roche completed its $3.5 billion acquisition of 89bio on Oct. 29, 2025, paying $14.50 per share in cash plus up to $6.00 per share in milestones. ETNB stock hit a 52-week high of $15.06 after the deal, reflecting a 52% premium. 89bio’s lead drug, pegozafermin, is in Phase 3 trials for MASH and SHTG. The company remains pre-revenue, reporting a $149 million net loss over the past year.
5 november 2025
Palantir Stock Skyrockets 150% – Inside the AI Defense Giant’s Epic 2025 Rally

Palantir Stock Skyrockets 150% – Inside the AI Defense Giant’s Epic 2025 Rally

Palantir Technologies’ shares have surged over 150% in 2025, hitting an all-time high near $207 before a post-earnings dip to the upper-$180s. Q3 revenue soared 63% to $1.18 billion, with U.S. commercial sales more than doubling. The company posted $0.18 GAAP EPS and $540 million in free cash flow. Michael Burry disclosed a large bearish bet, while Jim Cramer raised his price target to $200.
5 november 2025
···
Kratos Defense (KTOS) Soars 300% on Drone Boom – Is the Rally Sustainable?

Kratos Defense (KTOS) Soars 300% on Drone Boom – Is the Rally Sustainable?

Kratos Defense shares fell to the mid-$70s after Q3 revenue beat estimates but Q4 guidance missed forecasts, cutting market cap to $13 billion. The company announced a $356.3 million cash acquisition of Israel’s Orbit Technologies and raised 2025 revenue guidance. Year-to-date, the stock is up over 300%, hitting a 21-year high in October. Analyst consensus is “Moderate Buy” with targets ranging from $77 to $125.
5 november 2025
···
Orkla India IPO Listing Today: Shares List at 2.75–3% Premium, Slip Up to 7% Intraday; GMP, Subscription & Analyst Views (Nov 6, 2025)

Orkla India IPO Listing Today: Shares List at 2.75–3% Premium, Slip Up to 7% Intraday; GMP, Subscription & Analyst Views (Nov 6, 2025)

Orkla India shares opened at ₹750.10 on NSE and ₹751.50 on BSE, just above the ₹730 IPO price, but soon fell below it, dropping as much as 7% intraday. The debut missed grey-market expectations, which had pointed to a stronger start. The IPO, a ₹1,667.54 crore offer for sale, was subscribed nearly 49 times overall. Early-session market cap stood at about ₹10,295 crore.
6 november 2025
Pfizer (PFE) Stock at a Crossroads: Big Dividend, Weight-Loss Gamble & 2025 Outlook

Pfizer (PFE) today: Court denies bid to block Novo–Metsera deal; Pfizer preps sweeter offer and leans on higher 2025 EPS outlook

A Delaware court denied Pfizer’s request to block Metsera from ending their merger deal in favor of Novo Nordisk’s higher bid. Pfizer plans to raise its offer after Novo’s proposal reached up to $10 billion. FTC staff warned Novo’s bid structure could violate pre-merger rules. Pfizer shares traded near $24.61 midday Thursday.
6 november 2025
··
1 … 271 272 273 274 275 … 278
Go toTop